Development of a health economic model to demonstrate the costs and morbidity implications of an investigational obesity drug: technical report prepared for a US pharmaceutical company

Authors
Publication date
1 January 2004
Publisher
The Lewin Group

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    LSE Research Online

    redirect
    oaioai:eprints.lse.ac.uk:13762
    Last time updated on 10/02/2012